Insider Trades: Tesla, Citigroup, Morgan Stanley Among Notable Names This Week
FDA Pushes Potential Approval For Cytokinetics' Experimental Heart Drug By Three Months
The Strong Earnings Posted By Bristol-Myers Squibb (NYSE:BMY) Are A Good Indication Of The Strength Of The Business
Piper Sandler Maintains Bristol-Myers Squibb(BMY.US) With Buy Rating, Raises Target Price to $66
Piper Sandler Adjusts Bristol-Myers Squibb's Price Target to $66 From $65
Express News | UK's Mhra: Approved New Under-the-Skin Injection Version of Nivolumab (Opdivo)
